RxDoctor Payments Data

Steven Furr, DO

Family Medicine · Zwolle, LANPI 1063807584

Payments from drug & device makers

$287in general payments, 2019–2025

Across 15 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$75
  • Lilly USA, LLC$70
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$50
  • Mylan Specialty L.p.$25
  • Exact Sciences$18
  • Astellas Pharma US Inc$17
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$287100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$287 in reported general payments places this provider in the 35th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$7,915
Medicare patients
53
Services billed
77

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide84$76,141
JardianceEmpagliflozin57$46,720
MounjaroTirzepatide36$40,026
RybelsusSemaglutide30$29,984
FarxigaDapagliflozin Propanediol27$23,040
TrulicityDulaglutide23$22,301
EntrestoSacubitril/Valsartan23$20,234
LinzessLinaclotide21$16,106
EliquisApixaban13$12,966
XareltoRivaroxaban16$12,129
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,328
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,729
Albuterol Sulfate HfaAlbuterol Sulfate77$2,386
Pregabalin29$1,558
Atorvastatin Calcium143$1,547

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$75$106,125114 claims
Lilly USA, LLCMounjaro, Trulicity$70$62,32759 claims
Boehringer IngelheimJardiance$16$46,72057 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Zwolle

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →